The Epidemiology and Management of Pediatric AKI in Asia

Copyright © 2020 Elsevier Inc. All rights reserved..

Because of the lack of early recognition and referral, the incidence of pediatric acute kidney injury (AKI) in Asia still is underestimated. Although each diagnostic criteria has its own merits, the Kidney Disease Improving Global Outcomes classification now is widely accepted. In Asia, the spectrum of pediatric AKI is wide-ranging, from pediatric AKI in highly sophisticated tertiary-care pediatric intensive care units in resource-rich regions due to advanced procedures such as transplantation, cardiac surgery, and other hospital-acquired causes, to primary care preventable causes, such as infectious diseases, snakebite, and so forth in rural parts of the developing world. The development and application of novel biomarkers, concepts such as the Renal Angina Index and advanced renal replacement therapy have revolutionized the era of treating AKI, but the cost and feasibility are the key determinants, especially in rural areas. In view of availability and expenses, peritoneal dialysis should be the first choice in less-developed areas, however, because of various barriers, it still needs more effort. Effective educational steps to both medical carers and families are needed urgently.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:40

Enthalten in:

Seminars in nephrology - 40(2020), 5 vom: 14. Sept., Seite 516-532

Sprache:

Englisch

Beteiligte Personen:

Che, Ruochen [VerfasserIn]
Quadri, Mohammed Mazheruddin [VerfasserIn]
Zhang, Aihua [VerfasserIn]

Links:

Volltext

Themen:

Asia
Epidemiology
Journal Article
Pediatric acute kidney injury (AKI)
Renal replacement therapy
Review
Urinary biomarkers

Anmerkungen:

Date Completed 28.10.2021

Date Revised 28.10.2021

published: Print

Citation Status MEDLINE

doi:

10.1016/j.semnephrol.2020.08.008

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM318994593